Shvetank Bhatt

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Mesenchymal Stem Cells

Obsessive Compulsive Disorder

Top Venues

Expert opinion on therapeutic targets

Metabolic brain disease

Future medicinal chemistry

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yashika Tomar, Moushumi Baidya, Jay Chadokiya, Shvetank Bhatt, Gautam Singhvi
An overview of Skp2: a promising new therapeutic target of psoriasis. Expert opinion on therapeutic targets 28 (8) (2024)
Yashika Tomar, Moushumi Baidya, Jay Chadokiya, Shvetank Bhatt, Gautam Singhvi
An overview of Skp2: a promising new therapeutic target of psoriasis. Expert opinion on therapeutic targets (2024)
Yashika Tomar, Moushumi Baidya, Jay Chadokiya, Shvetank Bhatt, Gautam Singhvi
An overview of Skp2: a promising new therapeutic target of psoriasis. Expert opinion on therapeutic targets (2024)
Yashika Tomar, Moushumi Baidya, Jay Chadokiya, Shvetank Bhatt, Gautam Singhvi
An overview of Skp2: a promising new therapeutic target of psoriasis. Expert opinion on therapeutic targets 28 (8) (2024)
Sidhartha S Kar, Arghya Kusum Dhar, Narahari N Palei, Shvetank Bhatt
Small-molecule oligonucleotides as smart modality for antiviral therapy: a medicinal chemistry perspective. Future medicinal chemistry (2023)
Dinesh Kumar Chellappan, Asif Ahmad Bhat, Ahsas Goyal, Neelam Singla, Saurabh Gupta, Sanjay Sharma, Shvetank Bhatt, Kamal Dua
Exploring ACSL4/LPCAT3/ALOX15 and SLC7A11/GPX4/NFE2L2 as potential targets in ferroptosis-based cancer therapy. Future medicinal chemistry (2023)
Shvetank Bhatt, Kuttiappan Anitha, Dinesh Kumar Chellappan, Dhrubojyoti Mukherjee, Satish Shilpi, Ashish Suttee, Dinesh Kumar Chellappan, Thakur Gurjeet Singh, Kamal Dua
Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach. Metabolic brain disease (2023)
Dhrubojyoti Mukherjee, Shvetank Bhatt
Biocomposite-based nanostructured delivery systems for the treatment and control of inflammatory lung diseases. Nanomedicine (London, England) 17 (12) (2022)
Shvetank Bhatt, Thangaraj Devadoss, Niraj Kumar Jha, Moushumi Baidya, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh, Kamal Dua
Targeting inflammation: a potential approach for the treatment of depression. Metabolic brain disease (2022)